Boehringer Ingelheim Names Brian Hilberdink as President-US Human Pharma
Hilberdink will play a pivotal role in fostering Boehringer's culture and driving meaningful impact for patients.
Diabetes | 21/02/2025 | By Aishwarya
Kadimastem Shareholders Approve Merger with NLS Pharmaceutics
The merger brings NLS and Kadimastem one step closer to creating a combined Nasdaq-traded biotechnology company with a robust portfolio of advanced therapies for neurodegenerative diseases and diabetes.
Diabetes | 01/02/2025 | By Abha
Eris Lifesciences Announces Acquisition of Biocon Biologics
Eris Lifesciences Ltd. has recently acquired Biocon Biologics’ Branded Formulations business in India in a deal worth INR 1,242 crore.
Diabetes | 19/03/2024 | By Manvi | 197
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy